Interpace Biosciences, Inc. (IDXG)

Trade IDXG now with
3/11/2020 10:57:42 PM Interpace Diagnostics Updates Contract With BCBS Of Massachusetts
1/6/2020 7:01:43 AM Interpace Enters Collaborative Study To Assess Use BarreGEN After Ablation Of Dysplastic Barrett’s Esophagus
7/22/2019 6:59:07 AM Interpace Diagnostics Enters New Agreement With SelectHealth
7/15/2019 4:32:10 PM Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business
1/25/2019 6:02:19 AM Interpace Diagnostics Announces Pricing Of Public Offering Of 9.33 Mln Shares At $0.75/Shr
1/24/2019 4:36:18 PM Interpace Diagnostics Announces Proposed Public Offering Of Common Stock
1/22/2019 6:56:19 AM Interpace Diagnostics Finalizes Validation Of Third Specimen Type For Molecular Thyroid Tests ThyGeNEX And ThyraMIR
1/14/2019 6:57:18 AM Interpace Diagnostics Enters Deal With University Of Maryland Medical System
12/17/2018 6:52:35 AM Interpace Reports Notice Of Allowance From USPTO Covering BarreGEN
11/13/2018 4:27:48 PM Interpace Diagnostics Q3 Loss/share $0.11 Vs. Loss $0.15 Year Ago
10/4/2018 6:58:59 AM Interpace Diagnostics Enters Into Agreement With Renowned Integrated Health System
9/24/2018 6:59:16 AM Interpace Diagnostics: State Of Pennsylvania And New York Approve Commercialization Of Newest Thyroid Product, ThyGeNEXT
8/15/2018 8:32:12 AM Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
7/31/2018 8:37:11 AM Interpace Diagnostics Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement